Core Scientific (NASDAQ:CORZ – Get Free Report) had its target price lowered by equities research analysts at Cantor Fitzgerald from $26.00 to $25.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 55.18% from the stock’s previous close.
CORZ has been the topic of several other reports. BTIG Research upgraded Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Tuesday, January 6th. Zacks Research raised Core Scientific from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 13th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a research report on Wednesday, January 21st. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 target price for the company in a research note on Thursday, December 18th. Finally, Citigroup raised shares of Core Scientific from a “market perform” rating to an “outperform” rating in a research note on Thursday, December 18th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, four have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $24.41.
View Our Latest Stock Report on Core Scientific
Core Scientific Trading Down 2.3%
Core Scientific (NASDAQ:CORZ – Get Free Report) last posted its quarterly earnings data on Monday, March 2nd. The company reported $0.42 EPS for the quarter, topping the consensus estimate of ($0.27) by $0.69. The firm had revenue of $79.76 million for the quarter, compared to analysts’ expectations of $118.45 million. During the same period in the previous year, the firm earned ($0.69) earnings per share. The firm’s quarterly revenue was down 16.0% compared to the same quarter last year. Equities analysts anticipate that Core Scientific will post 0.52 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of CORZ. Allworth Financial LP lifted its position in Core Scientific by 206.5% during the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares during the period. Larson Financial Group LLC raised its stake in shares of Core Scientific by 936.7% in the fourth quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after purchasing an additional 1,686 shares during the last quarter. HHM Wealth Advisors LLC lifted its holdings in shares of Core Scientific by 96.5% during the second quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock worth $33,000 after purchasing an additional 946 shares during the period. Osaic Holdings Inc. lifted its holdings in shares of Core Scientific by 112.1% during the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock worth $34,000 after purchasing an additional 1,066 shares during the period. Finally, Danske Bank A S purchased a new stake in Core Scientific in the fourth quarter valued at approximately $36,000.
Key Stories Impacting Core Scientific
Here are the key news stories impacting Core Scientific this week:
- Positive Sentiment: Colocation revenue surged 268% year-over-year, signaling strong demand for Core Scientific’s high-density hosting business and improved unit economics for its digital infrastructure operations. Core Scientific Colocation Revenue Surges 268% Amid Mixed Q4 Results
- Positive Sentiment: Company-released results and slides show an earnings beat (reported EPS of $0.42 versus consensus of -$0.27) and management emphasized operational progress and RFS (ready-for-service) milestones. Those beats support the view that profitability can improve as colocation scales. Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results
- Neutral Sentiment: Management reiterated a 1.5 GW leasable pipeline (multi-geography builds) as a growth plan — a meaningful long-term positive for capacity and revenue but one that requires capital and execution. Investors are parsing timing and funding. Press Release / Expansion comment
- Neutral Sentiment: The earnings call transcript provides additional color on operations, margin drivers, and RFS timing for facility builds — useful for assessing cadence but not changing the mixed headline. Q4 2025 Earnings Call Transcript
- Neutral Sentiment: Reported short-interest data in the feed appears anomalous/zeroed-out and is not providing meaningful near-term signal for share pressure. (Treat as noise until validated.)
- Negative Sentiment: Revenue missed expectations materially: reported revenue was ~$79.8M versus analyst estimates near $118.5M, and sales were down ~16% year-over-year — a reminder that top-line recovery lags the profitability signal. Zacks: Key Metrics Versus Estimates
- Negative Sentiment: Some outlets reported Q4 results differently (one flagged a loss), contributing to market confusion and volatility. This inconsistency, combined with the revenue miss, pressured shares. Zacks: Reports Q4 Loss, Misses Revenue Estimates
- Negative Sentiment: Market reaction included an intraday share drop (~2.8% reported by some outlets) as investors weighed expansion risks, revenue shortfall, and the need for capital to scale the 1.5 GW pipeline. Blockonomi: Shares Drop as Company Pushes Forward with 1.5GW Expansion
About Core Scientific
Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
Featured Stories
- Five stocks we like better than Core Scientific
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
